Transcriptional activation of p21 (cyclin-dependent kinase inhibitor 1A) due to DNA damage often alters the distribution of histone variant H2A.Z at the p21 gene. However, whether the human INO80 complex regulates changes in H2A.Z at the p21 promoter is unclear. We show here that activation of p21 expression by doxorubicin (Doxo) in U2OS cells is required for removal of H2A.Z by INO80 at the p53-binding site proximal region (À2.2 kb) of the p21 promoter. A purified INO80 complex, but not the INO80E653Q mutant-complex, which lost DNA-sliding activity, is mainly responsible for removing H2A.Z from reconstituted nucleosomes in vitro. This activity was enhanced with MOF-mediated histone acetylation, suggesting that INO80 more readily removes H2A.Z from loosened nucleosomes. Also, co-occupancy of INO80 and H2A.Z À2.2 kb upstream of the p21 transcriptional start site (TSS) was observed. H2A.Z at this region was removed in a short time after Doxo treatment and activated p21 expression. However, p21 induction was inhibited by INO80 knockdown by delaying H2A.Z removal, indicating the need for INO80. Moreover, shMOF-mediated histone acetylation reduced recruitment of INO80 À2.2 kb upstream of p21 TSS and inhibited the removal of H2A.Z in Doxo-treated cells. These data provide new insights into the transcriptional regulation of p21 by the INO80 complex.
Introduction
H2A.Z is an evolutionarily conserved variant of the canonical histone H2A in yeast and human with various intracellular functions, such as DNA damage repair, genomic stability maintenance, and gene transcription [1] [2] [3] . How H2A.Z regulates transcription is not clear, but the genomic loci for H2A.Z may influence gene activation or silencing via altering chromatin structure. For instance, in triple negative breast cancer cells, H2A.Z could bind to the promoter region and inhibits the expression of cyclin D1 oncogene (CCND1). In contrast, removing H2A.Z from the transcriptional start site (TSS) and downstream enhancer (enh2) sequences activates CCND1 [4] , suggesting the critical role of H2A.Z in regulating genome expression and maintenance. In addition, the N-terminal tail of H2A.Z can be acetylated [5, 6] , and acetylated H2A.Z (H2A.Zac) is frequently localized to the promoter region of active genes [7] .
The presence of H2A.Z at specific loci must be maintained by chromatin remodelers. The yeast Swr1 chromatin remodeling complex and its two homologs in human SRCAP and p400/TIP60 complexes incorporate H2A.Z into nucleosomes [8] [9] [10] and H2A.Z deposition at specific loci in chromatin is often affected by histone modification. In yeast, SAS-mediated acetylation of histone H4 Lys16 (H4K16ac) regulates incorporation of H2A.Z at a subtelomeric region [11] . Also, ATPase activity of p400 and Tip60-mediated histone acetylation contribute to incorporate H2A.Z into nucleosomes during DNA damage [12] , suggesting that histone acetylation may promote reorganization of the chromatin architecture and assemble DNA damage repair machinery [2] . Although it is currently considered that INO80 chromatin remodeling enzyme may be involved in the removal of H2A.Z, how this occurs is unclear. In human cells, H2A.Z chaperone acidic nuclear phosphoprotein 32 family member E (ANP32E) also reported to be involved in removing H2A.Z from nucleosomes by interacting with the Cterminal docking domain of H2A.Z [13] , indicating the existence of more complex mechanisms in human cells.
The shared core subunits between yeast and human ATP-dependent INO80 chromatin remodeling complexes assemble on conserved ATPase and helicase-SANT-associated/post-HSA (HSA/PTH) domains of the INO80 catalytic protein to maintain nucleosome sliding and ATPase activity [14, 15] . The INO80 complex which lacks core subunits Arp4 and Arp8 is defect in DNA binding and nucleosome remodeling activity [16] , which in turn affects gene transcriptional regulation. p21, a universal inhibitor of cyclin kinases, has been implicated in many cellular processes and tumorigenesis [17, 18] . Two highly conserved p53 response elements (PRE) in the p21 promoter region can be recognized and bound by activated tumor suppressor p53 to induce transcriptional activation of the p21 gene [19] . The INO80 complex not only occupies p53-binding sites of the p21 promoter, but also negatively regulates p21 expression in a p53-dependent manner [20] . Meantime, expression of p21 is associated with localization of H2A.Z, and dynamics of H2A.Z loci are regulated by chromatin remodelers via catalyzing nucleosome sliding and exchange of H2A.Z with H2A. For example, p400-mediated H2A.Z deposition at the p53-binding site proximal region of the p21 promoter can suppress p53-mediated p21 transcription [21, 22] , whereas removal of H2A.Z from these sites may activate p21 transcription. Expression of p21 is regulated by the INO80 complex in human cells, but whether INO80 is involved in removal of H2A.Z from the p53-binding site proximal region of the p21 promoter, and whether this activity is facilitated by histone acetyltransferase (HAT) MOF-mediated histone acetylation is unclear. Also, it is not known whether removing H2A.Z from nucleosomes is coordinating with other mechanisms. In addition, as an inhibitor of topoisomerase, doxorubicin (Doxo) can intercalate into DNA to induce programmed cell death; therefore, it has been used as a chemotherapeutic drug for over 30 years [23] . One of the characteristics of Doxo in cells is the ability to induce potent senescence inducers, including p53, PAI-1, and p21 [24] . Therefore, as an effective model, we specifically investigated how INO80 removes H2A.Z during Doxo-activated p21 expression.
Results

Doxo-induced p21 expression was regulated by human INO80 chromatin remodeler (INO80) in U2OS cells
In order to determine the best conditions for p21 induction by Doxo, we first optimized the concentration of Doxo that could induce the highest level of p21 expression in U2OS cells, as determined by qPCR and western blot. The highest expression of p21 mRNA (Fig. 1A , column 2) and protein (Fig. 1B, lane 2) was observed by treatment with 0.5 lM of Doxo for 12 h. However, in line with published reports [25] , higher concentration of Doxo leads to cell death (Fig. 1C) , the cell survival rate also decreased along with drug concentration increases (Fig. 1E ). It should be emphasized that under our experimental conditions, the induction of senescence was not detected by senescence-associated b-gal (SA-b-gal) staining (Fig. 1C,D) . Thus, 0.5 lM Doxo was used for p21 induction in subsequent experiments. To further understand the effect of 0.5 lM Doxo on the cell cycle, fluorescenceactivated cell sorting (FACS) analysis was performed at different times (Fig. 1F) . Quantified subpopulation of cells in cell cycle phase G1, S, and G2/M is shown in Fig. 1G . It is clear that no obvious cell cycle arrest appeared at any other time except 24 h. Therefore, we decided that in a follow-up experiment, the treatment of cells with 0.5 lM Doxo should not exceed 12 h. Next, to understand how INO80 affects Doxo-induced p21 expression, detection of p21 at multiple time points was performed after INO80 knockdown with siRNA. As an example, the knockdown efficiency of INO80 at 12 h after Doxo treatment is shown in Fig. 1H . In agreement with our previous report [20] , upregulation of p21 in both mRNA and proteins was observed by knocking down INO80 with siRNA at 0 h of Doxo treatment (Fig. 1I-K) . However, compared with the nontargeting siRNA (siNT) group, in which rapid increases in p21 mRNA (Fig. 1I ) (**P < 0.01 at 12 h) and protein ( Fig. 1J ) expression induced by Doxo were measured, the induction of p21 was obviously slowed by knocking down INO80. Quantified protein levels are shown in Fig. 1K (**P < 0.01 at 6, 8, and 12 h), suggesting the involvement of INO80 in regulating Doxo-induced p21 expression.
Co-occupancy of INO80 and histone variant H2A.Z at the p53-binding site (À2.2 kb) proximal region of the p21 promoter was detected in U2OS cells
Because the p21 expression is associated with both INO80 and the localization of H2A.Z [21] , it was hypothesized that INO80 and H2A.Z coordinate to affect Doxo-induced p21 expression. To address this issue, the impact of H2A.Z on p21 expression was first tested under our experimental condition. As shown in Fig. 2A , upregulation of both p21 mRNA (left) and protein (right) was observed when H2A.Z was knocked down with siRNA. In addition, to understand the crosstalk between INO80 and H2A.Z in the transcriptional regulation of p21, ChIP experiments were arranged to address whether INO80 and H2A.Z cooccupy the p21 promoter region. Six primer sets were designed to yield ChIP DNA for the p21 promoter proximal region, including two p53-binding sites (À2.2 and À1.0 kb) (Fig. 2B) . As the results show, there is a high H2A.Z enrichment peak À2.2 kb upstream of the p21 TSS (Fig. 2C) . To further confirm that H2A.Z was corecruited with INO80 at this binding site, a sequential ChIP (Re-ChIP) was carried out (Fig. 2D ). As expected, higher fold enrichment was only observed in H2A.Z-H2A.Z and H2A.Z-INO80 Re-ChIP, clarifying that INO80 and H2A.Z co-occupy the p21 promoter À2.2 kb upstream of the TSS (Fig. 2E ).
The distribution of H2A.Z at genomic TSSs and in the chromatin fraction was regulated by INO80
To further investigate the crosstalk between INO80 and H2A.Z, ChIP-Seq analysis was first performed using H2A.Z and H2A.Zac antibodies in pLVX-shINO80-and pLVX-shArp8-transfected cells. The knockdown efficiency of INO80 or Arp8 and the indicated proteins were visualized by WB (Fig. 3A,B) . ChIP DNA was sent for ChIP-Seq analysis. All genes were sorted to create the heatmap according to their ChIP-Seq reads at the TSS regions (~À3.0 to +3.0 kb) (Fig. 3C,D) . In addition, the quantified enrichment, which showed the compilation of all genomic-binding sites relative to the TSS regions, was presented in Fig. 3E ,F. Like the previous reports [7, 25] , H2A.Z and H2A.Zac flanked the TSSs and were mostly distributed at the +1 and À1 nucleosomes. Compared to the shNT group, the genome-wide enrichment pattern of both H2A.Z and H2A.Zac was visibly higher around TSSs in INO80-knockdown cells, suggesting the role of INO80 in regulating the distribution of H2A.Z at TSS regions by means of promoting H2A.Z removal. However, this behavior was almost undetectable in Arp8-knockdown cells.
Next, chromatin fractionation experiments in HCT116 cells (Fig. 3G ) further confirmed the regulation of H2A.Z distribution by INO80. As shown in Fig. 3H , although there was no notable change of global H2A.Z in the whole cell lysate, remarkably increased H2A.Z in the chromatin fraction of INO80-knockdown cells was observed (Fig. 3I, lane 4) . A statistically significant difference in H2A.Z levels between shNT-and shINO80-transfected cells was witnessed (**P < 0.01) (Fig. 3J ). INO80 was mainly responsible for removal of H2A.Z at the p53-binding site proximal region (À2.2 kb) of the p21 gene in U2OS cells
The above experimental results suggest that INO80 may be involved in regulating the distribution of H2A.Z at specific loci in genes. This prompted us to investigate whether the regulation of Doxo-mediated p21 expression by INO80 is associated with its control of H2A.Z distribution in the p21 promoter region. To address this speculation, dynamic changes of INO80 and H2A.Z in the p21 promoter region (À2.2 and À0.3 kb) were tested by ChIP assays using INO80-and H2A.Z-specific antibodies after 0.5 lM Doxo treatment. As a result, both INO80 and H2A.Z, which were originally enriched at the p53-binding site proximal region of the p21 promoter (À2.2 kb), were decreased by treating cells with 0.5 lM Doxo in a short period of time; however, this behavior was not observed at the À0.3 kb site in Doxo-treated cells (Fig. 4A) . In order to better understand the regulatory relationship between INO80 and H2A.Z in their effect on p21 induction by Doxo, shRNA plasmids, encoding nontargeting control (pLVX-shNT), and INO80 (pLVX-shINO80-1 or pLVX-shINO80-2), were constructed. After confirmed the INO80-knockdown efficiency (Fig. 4B) , pLVX-shINO80-1 was chosen for subsequent experiments. At first, the impact of INO80 on the distribution of H2A.Z at different sites in the p21 promoter region was checked. As shown in Fig. 4C , knockdown of INO80 increased enrichment of H2A.Z at the p53-binding site (À2.2 kb) in the p21 promoter. After this, the dynamics of H2A.Z À2.2 kb upstream of the p21 TSS were examined. As expected, quick removal of H2A.Z À2.2 kb upstream of the p21 TSS was obviously delayed by knocking down INO80 (Fig. 4D ) (**P < 0.01 at 1 h and *P < 0.05 at 2 h compared to the shNT group), suggesting that INO80 plays a role in removing H2A.Z from the p53-binding site in the p21 promoter after treating cells with Doxo. This result was further confirmed by biological repeats and rescue experiments. INO80-knockdown U2OS cells with or without 1 h Doxo treatment (Fig. 4E) were subjected to H2A.Z ChIP. In both situations, increased enrichment of H2A.Z À2.2 kb upstream of p21 TSS was observed in shINO80-1 group compared those to shNT. However, this phenomenon was more obvious in 1 h Doxo-exposed cells (Fig. 4F , **P < 0.01). Similar results were also observed on p53-binding site of proapoptotic BAX (Fig. 4G , *P < 0.05, **P < 0.0.1) [21] . In order to confirm, the above results were related to INO80, rescue experiment was performed. As shown in The ChIP experimental results strongly suggested that the INO80 complex is involved in removing H2A.Z from the p53-binding site proximal region of the p21 promoter. Therefore, we decided to validate the ChIP results with an in vitro H2A-H2A.Z-exchange assay. To do that, recombinant human histone octamers containing H2A/H2B/H3/H4 or H2A.Z/H2B/H3/H4 and dimers containing Flag-H2A/Myc-H2B or Flag-H2A.Z/Myc-H2B [ Fig. 5A , Coomassie brilliant blue (CBB)-stained protein gel] were used in in vitro assays. H2A-and H2A.Z-containing nucleosomes were assembled with recombinant histone octamers and biotinylated DNA using a serial dilution approach. Reconstituted nucleosomes were then precipitated with streptavidin-coupled Dynabeads (Dynal Biotech, Invitrogen, Waltham, MA, USA), and selected histones were detected by WB with specific antibodies (Fig. 5B) . The INO80 complex used in in vitro assays was obtained through immunopurification from 293FRT cells, which were stably expressing a Flagtagged-specific subunit (INO80wt, INO80E653Q/ INO80mt, Arp8, and Ies6) of the INO80 complex, and the purified polypeptides were visualized by silver staining (Fig. 5C ). After this, according to the method shown in Fig. 5D , in vitro H2A-H2A.Z-exchange assays were carried out by mixing H2A.Z-containing nucleosomes, Flag-H2A/H2B dimers, and purified INO80 complexes in the presence of ATP. As expected, the INO80 complexes purified from Flag-INO80wt, FlagArp8, and Flag-Ies6 stable cell lines were capable of removing H2A.Z from reconstituted H2A.Z-containing nucleosomes in a dose-dependent manner (Fig. 5E , IB: H2A.Z/lane 2-3, 6-7, and 10-11). Simultaneously, the amount of Flag-H2A in nucleosomes was dosedependently increased (Fig. 5E , IB: Flag/lane 2-3, 6-7, and 10-11), suggesting that an exchange between H2A and H2A.Z occurred. However, catalytically dead human INO80 complexes (INO80mt, INO80E653Q) that had lost their DNA-sliding activity [15] no longer possessed the enzymatic activity for removing H2A.Z from reconstituted nucleosomes with or without ATP (Fig. 5F , lane 3-4) compared to the INO80wt complex (Fig. 5F, lane 1-2) .
We previously reported that human SRCAP complex can incorporate H2A.Z into nucleosomes [9] . To clarify whether the INO80 complex has the same catalytic activity, in vitro H2A-H2A.Z-exchange assays were further performed using H2A-containing nucleosomes and Flag-H2A.Z/H2B dimers. Assembled nucleosomes (Fig. 6B ) and anti-Flag immunopurified complexes from Flag-YL1 (a shared subunit between SRCAP and p400/TIP60 complexes), Flag-TIP49a (a shared subunit between INO80, SRCAP, p400/TIP60 complexes), and Flag-INO80wt and Flag-INO80mt stable cell lines (Fig. 6A) were used in this experiment. H2A.Z-incorporation assays were done by mixing the relative equivalent amount of proteins from the indicated complexes, dimers and assembled nucleosomes for 60 min in the presence or absence of ATP (Fig. 6C) . Both Flag-YL1 and Flag-TIP49a complexes were capable of depositing H2A.Z into reconstituted nucleosomes in an ATP-dependent manner (Fig. 6D,  lanes 2 and 4) . Although the INO80wt complex appeared to have weaker activity (lane 6) compared to the INO80mt complex (lane 8), the enzymatic activity was negligible compared to the YL1 complex (lane 2), indicating that the INO80 is mainly responsible for removing H2A.Z from reconstituted nucleosomes. Likewise, neither YL1 nor TIP49a have the enzymatic activity for removal of H2A.Z from reconstituted nucleosomes (Fig. 6E) .
MOF-mediated histone acetylation facilitated the removal of H2A.Z by INO80 from reconstituted nucleosomes Human INO80 and MOF-containing complexes are connected by a shared subunit MCRS1 (Microspherule Protein 1) [14, 26] . This raises the possibility of functional links between the two complexes. To study the crosstalk between MOF-mediated acetylation and the H2A.Z-removing activity of INO80, global acetylation of histone H4 at lysine 16 (H4K16ac) and H2A.Z (H2A.Zac) was first measured after overexpressing or knocking down MOF. As shown in Fig. 7A ,B, both H4K16ac and H2A.Zac in U2OS cells were up-or downregulated by overexpressing or knocking down MOF, respectively. Furthermore, purified MOF-containing complexes from a stably expressing Flag-MOF cell line (Fig. 7C, left) were subjected to in vitro assays to test their HAT activity. After confirming the HAT activity of the MOF complex (Fig. 7C, right) , mixed HAT/ H2A.Z-exchange assays were carried out using MOF and INO80 complexes in the presence or absence of AcCoA. It is clear that the activity of removing H2A.Z from reconstituted nucleosomes by the INO80 complex was facilitated by the MOF-containing complex in an AcCoA-dependent manner (Fig. 7D, lane  2) . To further confirm this phenomenon, reconstituted H2A.Z-containing nucleosomal arrays were used as a substrate, and a sequential in vitro assay was carried out. A scheme of the assay is shown in Fig. 7E . After removing HATs, dose-dependent promotion of H2A.Z-removing activity by INO80 can still be observed in the lane for which the initial HAT assay was performed with hMOF (Fig. 7F, lane 3-4) . This suggested that the MOF complex, with respect to acetylation of histone H4K16, might be important for promoting subsequent H2A.Z exchange via the INO80 complex. However, whether H2A.Zac is also involved in the promotion of INO80-exchange activity cannot be determined because the specific acetylated (Lysine 4, 7, and 11) H2A.Z antibody (ab18262; Abcam, Cambridge, UK) used in our experiments was unable to detect H2A.Zac in the reconstituted nucleosomes.
MOF-mediated histone acetylation might be implicated in transcriptional regulation of INO80 on the p21 gene
The enhancement of INO80-exchange activity by MOF-containing HAT has been verified using an in vitro assay, but the question is whether this correlation is also applicable in cells. To address this question, the impact of MOF on p21 induction by Doxo was tested. Interestingly, except for p21 induction, the global histone H4K16ac was also increased in 0.5 lM Doxo-treated U2OS cells, and this higher level of H4K16ac remained until 12 h (Fig. 8A, left panel) . However, overall p21 expression and global histone H4K16ac levels were decreased by knocking down MOF compared with those of the shNT group (Fig. 8A, right panel) . The above results suggest that histone H4K16ac may be implicated in Doxo-induced p21 expression. To know whether the p21 induction by Doxo is coregulated by MOF and INO80, the following experiments were designed, as indicated in Fig. 8B ,C. In line with previous experimental results, Doxo-induced p21 expression (12 h) in both mRNA and proteins was inhibited by knocking down MOF or INO80. However, although knockdown of both MOF and INO80 further reduced p21 mRNA levels compared with those of knockdown alone (Fig. 8B , **P < 0.01), there was no significant difference in protein levels (Fig. 8C, lane 8 compared with lanes 6 and 7) . To further investigate the cooperation between MOF and INO80, lentiviral-mediated pLVX-shMOF-1 and pLVX-shMOF-2 cell lines were established. As shown in Fig. 8D , global histone H4K16ac was remarkably decreased by knocking down MOF. Afterwards, ChIP assays were performed using H4K16ac, H2A.Zac, and INO80 antibodies in pLVX-shNT-and pLVX-shMOF-1-transfected cells. As expected, knocking down MOF resulted in a declined distribution of H4K16ac (Fig. 8E , **P < 0.0.1) and H2A.Zac (Fig. 8F) À2.2 kb upstream of the p21 TSS. A decrease in histone acetylation further suppressed INO80 recruitment locally (Fig. 8G , **P < 0.01). In order to clarify whether MOF-mediated histone acetylation was involved in H2A.Z distribution in the process of Doxo-induced p21 expression, H2A.Z ChIP was carried out in MOF-knockdown cells with or without Doxo-treatment (0, 1, and 2 h). As shown in Fig. 8H , compared to non-Doxo-treated cells, much higher enrichment of H2A.Z À2.2 kb upstream of the p21 TSS was found in MOF-knockdown cells with a 1 or 2 h Doxo-treatment (**P < 0.01).
Discussion
Genome-wide dynamics of H2A.Z at specific loci can be regulated by ATP-dependent chromatin remodelers. Yeast Swr1 or its homologous in mammals including p400/TIP60 and SRCAP complexes can deposit H2A.Z into nucleosomes [8] [9] [10] , but how H2A.Z is removed from nucleosomes is not clear [27, 28] . It is generally accepted that the INO80 complex is involved in removing H2A.Z from nucleosomes. In budding yeast, removal of H2A.Z by INO80 is implicated in gene transcription [29] and presynaptic filament formation during homologous recombination (HR) [30] . In human cells, removal of H2A.Z may require multiple regulatory mechanisms. For example, INO80 and ANP32E contribute to the removal of accumulated H2A.Z in damaged chromatin induced by laser microirradiation in vivo, and removal of H2A.Z from chromatin is the primary function of INO80 and ANP32E in promoting HR [13, 31] . However, the removal of H2A.Z by INO80 complex has not been confirmed in human cells. Here, we clarified that the human INO80 complex is mainly responsible for removing H2A.Z from H2A.Z-containing reconstituted nucleosomes in an ATP-dependent manner and that INO80 can be facilitated by HAT MOF-mediated histone acetylation in an Acetyl-CoA-dependent manner. On the other hand, the increased enzymatic activity of INO80 is tightly associated with histone H4K16 acetylation, since in in vitro sequential HAT-exchange assays, removal of H2A.Z from reconstituted nucleosomes by INO80 could still be facilitated after wash out the MOF-containing protein complex. Thus, it is likely that H4K16ac directly reduced internucleosome interaction mediated by the H4 tail, which may encourage binding of nonhistone proteins on the acidic patch [32] . Also, H4K16ac may also weaken interactions between H4 tail and neighboring nucleosomes, resulting in a loosened chromatin structure, promoting removal of H2A.Z-H2B dimers [32] . This makes it easy to understand why knocking down MOF not only reduces the recruitment of H4K16ac at the p53-binding site proximal region of the p21 promoter, but also affects the recruitment of INO80 at the same local in cells. Moreover, in Doxo-exposed U2OS cells, knocking down MOF increased the enrichment of H2AZ at the p53-binding site proximal region of the p21 promoter compared those to non-Doxo-treated cells.
ATP-dependent nucleosome remodeling is another important activity of the INO80 complex. In yeast and murine embryonic stem cells, the INO80 complex can recruit to the TSS region and directly repress promoter-proximal nucleosome remodeling to limit transcription [33, 34] . This may explain why knocking down INO80 increases p21 transcription. Studies confirm the involvement of p53-mediated mechanism in regulating p21 transcription by INO80 [20] . In our ChIP and re-ChIP assays, H2A.Z was co-occupied with INO80 at the p53-binding site proximal region of the p21 promoter, suggesting that H2A.Z removal by INO80 might be involved in p53-mediated transcriptional regulation of p21. That is, INO80 has complex actions on transcriptional regulation of genes. Greater enrichment of H2A.Z and H2A.Zac around TSS was observed in shINO80-transfected cells, indicating the involvement of INO80 in regulating the genome-wide distribution of H2A.Z at the TSS region. However, this behavior was scarce in Arp8-knockdown cells perhaps because knocking down Arp8 affects chromatin remodeling of INO80 rather than H2A.Z removal by INO80. Thus, the INO80 complex is defective in DNA binding and nucleosome remodeling activity by lacking Arp8 cells [16] and the INO80E653Q mutant-complex which lost DNA-sliding activity [15] no longer could remove H2A.Z. Of course, it does not rule out subcomplex of INO80 which may involve in H2A.Z removal process independent to Arp8.
Chromatin remodeling and H2A.Z removal by the INO80 complex is key to gene transcription regulation and this may rely on the intracellular environment. In normal conditions, the INO80 complex may directly inhibit p21 expression by repressing promoter-proximal nucleosome remodeling [33, 34] . Therefore, knockdown of INO80 released this inhibitory effect on the promoter region and caused p21 expression. In addition, p400/TIP60-dependent H2A.Z deposition is a repressive barrier to p53-dependent p21 activation [21] , which may be another pathway for inhibiting p21 expression under normal circumstances. However, when cells are exposed to genotoxic agents such as UV light and Doxo, p53 protein is activated via phosphorylation and binds to p53-responsive elements of the p21 gene [35] . For example, Genotoxic agents induced p53-serine 15 phosphorylation (p53S15P) is required for efficient recruitment of p53 to chromatin [20, 35] . On the other hand, DNA damage response molecules such as H2AX and H2A.Z gathered at the damages site [36] and removed it. The removal of H2A.Z at the p53-binding site region of the p21 promoter fully activates p21 in response to cellular stress in U2OS cells [21] , suggesting that H2A.Z removal is key to regulating Doxo-induced p53-mediated p21 expression. Knocking down INO80 delayed removal of H2A.Z at the p53-binding site region of the p21 promoter in Doxo-treated U2OS cells, suggesting the involvement of INO80 in removing H2A.Z to activate p21 expression during DNA damage caused by Doxo in a p53-dependent manner. In line with this, the highly enrichment of H2A.Z at the p53-binding sites proximal region of p21 promoter in (p53+/+), osteosarcoma SAOS-2 cells, but not in (p53À/À) osteosarcoma SAOS-2 cells [21] , thus, we speculate that INO80-mediated removal of H2A.Z from p21 promoter is equally effective in osteosarcoma SAOS-2 cells. In addition, MOF may be involved in p21 activation by Doxo because p21 induction and global H4K16ac increased with Doxo treatment. Also, in Doxo-treated U2OS cells, knocking down MOF inhibited removal of H2A.Z at the p53-binding site region of the p21 promoter, perhaps due to low H4K16ac leading to local chromatin structure condensation and inhibition of H2A.Z removal by INO80. In addition, chromatin relaxation between DNA and nucleosomes caused by Doxo's insertion into DNA [37] may also contribute to H2A.Z removal by INO80.
Taken together, transcriptional regulation of INO80 on p21 is coordinated by various mechanisms. With normal cellular conditions, INO80 represses p21 expression by regulating the promoterproximal nucleosome arrangement. However, in Doxo-treated cells, INO80 rapidly removes accumulated H2A.Z, and the inhibitory effect of H2A.Z on p21 is released, inducing p21activation. In addition, H4K16ac by MOF may also contribute to INO80-mediated H2A.Z removal by relaxing chromatin. However, how INO80 and p400/TIP60 switch functions to control H2A.Z in/out of chromatin is not clear and whether the crosstalk of INO80-H2A.Z regulates other target genes is not known. Given that H2A.Z and INO80 are involved in diverse gene regulations, more studies are needed to describe how INO80 and H2A.Z coordinate transcriptional regulation within the genome.
Methods
Antibodies
Anti-p21 (10355-1-AP), anti-Histone H4 (16047-1-AP), and anti-INO80 (24819-1-AP, used for WB analysis) were purchased from Proteintech Group (Wuhan, China). Anti-INO80 (residue 1-526aa, used for ChIP analysis), anti-Arp8, anti-GAPDH and anti-H2B rabbit polyclonal antibodies were raised against bacterially expressed proteins (Jilin University). Anti-H2A.Z (ab4174) and anti-H2A.Zac (acetyl K4/K7/K11, ab18262) were from Abcam. Anti-H3 was obtained from Ruiying Biological (Suzhou, China). AntiH4K16ac (H9164) polyclonal antibody, anti-Flag M2 (F3165) were from Sigma (St. Louis, MO, USA). Anti-MOF (BM1942) monoclonal antibody got from Boster (Wuhan, China). Anti-H4K5ac (07-327) and anti-H4K8ac (07-328) polyclonal antibodies were purchased from Merck Millipore (Darmstadt, Germany).
Cell culture, chemical treatment, and transient transfection U2OS cells were cultured in Dulbecco's Modified Eagle's Medium (Gibco Life Technologies TM , Gaithersburg, MD, USA), and HCT116 cells were cultured in RPMI 1640 Medium (Gibco Life Technologies TM ). U2OS and HCT116 cells were maintained in medium containing 10% fetal bovine serum (KangYuan Biology, Tianjin, China) and 1% penicillin-streptomycin (Thermo-Fisher Scientific, Waltham, MA, USA). Doxorubicin hydrochloride (D1515) was from Sigma and used at 0.5 lM to induce DNA damage.
Quantitative real-time PCR
RNA was isolated from cells with TRIzol plus RNA purification Kit (D9109; Takara, Tokyo, Japan). cDNA synthesis was done with PrimeScript 1st Strand cDNA synthesis Kit (Takara). mRNA was measured using quantitative real-time PCR (qPCR) with Eco Real-Time PCR System (Illumina, Gene Company Limited, Hong Kong, China). The PCR reactions were conducted as previously described [20] . The following primer sets were used for qPCR analysis: Immunoaffinity purification of protein complexes 
Preparation of the histone octamers and mononucleosomes
Recombinant human histone octamers, mononucleosomes (used 216 bp DNA fragment) were prepared as previously described [39] . Assembled nucleosomes were then immobilized on Dynabeads M-280 Streptavidin (11206D; Invitrogen).
In vitro H2A.Z-exchange and histone acetyltransferase assays
Histone H2A-or H2A.Z-containing reconstituted nucleosomes, Flag-tagged H2A-H2B or Flag-H2A.Z-HB dimers, anti-Flag-agarose eluates prepared from stably expressing specific proteins were used in in vitro histone variant H2A.Z-exchange assay [39] . Histone acetyltransferase assay was performed as described [40] . Briefly, reaction buffer containing 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 5% (v/v) glycerol, 1 mM phenylmethylsulfonyl fluoride, 10 mM sodium butyrate mixed with acetyl coenzyme A (205 lM), 1.4 pmol reconstituted nucleosomes, and anti-FLAG-agarose eluates prepared from FLAG-MOF-expressing 293FRT cells were incubated at 30°C for 60 min. Aliquots of reaction mixtures were then subjected to 18% SDS/PAGE gel. Acetylated histones were visualized using western blot with specific lysine acetylated antibodies.
siRNA/shRNA knockdown Nontargeting (NT) (D-001206), INO80-(D-004176), MOF-(D-014800) siRNA SMART pool (Dharmacon, Shanghai, China), and H2A.Z siRNA from Genepharma (Shanghai, China) were used. Cells were transfected with siRNA using Lipofectamine RNAiMAX (13778150; Invitrogen). In addition, a pLVX-shRNA system including INO80, Arp8, and hMOF were used. pLVX-shRNA plasmids were transiently transfected using polyethylenimine (Cat No. 23966; Polysciences, Beijing, China) according to the manufacturer's recommendation. After shRNA sequences were targeted to INO80, Arp8 and hMOF were used in knockdown experiments: shINO80-1, CGACA AACGTCAGCTATCTTCAATA; shINO80-2, CAGGAGG ATTATGATAGTAACCATT; shARP8, GAGGTGGTTTG ATGTTTCA; shMOF-1, GTGATCCAGTCTCGAGTGA; shMOF-2, CGAAATTGATGCCTGGTAT.
ChIP assay
Cells were cultured and grown to 80-90% confluence in a 10-cm plate. ChIP and Re-ChIP experiments were performed with antibodies directed against H2A.Z, H2A.Zac, Ino80, H2B, and H4K16ac according to a standard protocol. ChIP DNA was amplified with qPCR. Each experiment was performed 2-3 times. Antibodies and IgG-ChIP signals were normalized to total input. qPCR primers were: p21 À2.5 kb (À2494 to À2380 bp), 5 0 -ACATTGTTCCCAGCACTTCC- 
Analysis of ChIP-Seq data
pLVX-shINO80 and pLVX-shArp8 transfected HCT116 cells were grown to 80-90% confluence in RPMI 1640 medium containing 10% FBS. After confirming knockdown of INO80 and Arp8, H2A.Z and H2A.Zac ChIP assays were performed, and ChIP DNA was sent for ChIP-Seq analysis (BerryGenomics, Beijing, China) using Illumina HiSeq 2500 as singleend 50 base reads according to a standard protocol. ChIP-Seq reads were mapped onto the human genome sequence (GRCh37/hg19). Only uniquely mapped reads were used for peak identification. H2A.Z and H2A.Zac peak detection was performed with MACS (v1.4.2) with P < 10 À8 (http://liulab.dfc i.harvard.edu/MACS/). Heatmaps and quantitative enrichment comparisons of ChIP-Seq data were plotted using the 'gplot' package in R software (http://www.r-project.org/).
FACS analysis
Cells treated with 0.5 lM of Doxo for 0, 2, 4, 6, 8, 12, and 24 h were harvested by trypsinization. 10 6 cells were suspended and fixed as single cell dispersions in 70% ethanol at 4°C overnight. After washing twice with PBS, cells were resuspended in propidium iodide buffer (CF0031; Beijing Dingguo, Beijing, China), then incubated at 37°C for 30 min. Data collection was performed using EPICXLTM Cytometers (Beckman Coulter, Brea, CA, USA). Acquired data were analyzed using MODFIT LT software (Verity Software House, Topsham, ME, USA).
SA-beta-gal analysis
Cells in culture were fixed for 15 min at room temperature using a senescence b-galactosidase staining kit (C0602; Beyotime, Shanghai, China). After washed three times with PBS, cells were incubated overnight at 37°C with SA galactosidase stain solution.
Cell viability analysis 5 9 10 3 cells/well in 96-well plate were treated with 0, 0.5, 1, 2, 4, and 10 lM Doxo for 12 h, respectively. Then, cells were incubated with cell counting Kit-8 (CCK-8) (C0038; Beyotime) for 1 h. The absorbance at 450 nm was measured using a microplate reader (Infinite F200 Pro; TECAN, Shanghai, China).
Statistical analysis
Results are expressed as the means standard error (SEM).
Comparisons between two groups were made with an unpaired Student's t-test.
